These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2684368)

  • 1. [Screening of antibodies to human T-cell leukemia virus type I (HTLV-I) in sera of blood donors and comparison of different methods].
    Fan FS; Lin DL; Yeh HM; Chen MS; Su JL; Lin SH; Tzeng CH; Chuang MW; Liu JH; Hsieh RK
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Jul; 44(1):71-6. PubMed ID: 2684368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of anti-HTLV-1 in physical-checkup individuals and blood donors in Taiwan.
    Yung CH; Chow MP; Hu HY; Tzeng JL; Wu YS; Lyou JY; Liu WT
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):244-51. PubMed ID: 1342641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serological evaluation of human T lymphotropic virus type-I infection in routine hospital samples, especially using serodia.HTLV-I].
    Kamihira S; Nakashima S; Fukahori Y; Toriya K; Kanamura M; Ohta T
    Rinsho Byori; 1990 Jul; 38(7):783-8. PubMed ID: 2205742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunofluorescence, enzyme-linked immunosorbent assay, particle agglutination and western blot for the detection of antibody to human immunodeficiency virus type 1.
    Auwanit W; Ayuthaya PI; Balachandra K; Jayavasu C; Phanthumachinda B; Ikuta K; Yamanishi K; Kanai K
    Southeast Asian J Trop Med Public Health; 1990 Mar; 21(1):53-9. PubMed ID: 2205928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative diagnostic assay results for detecting antibody to HTLV-I in Japanese blood donor samples: higher positivity rates by particle agglutination assay [corrected].
    Ishizaki J; Okayama A; Tachibana N; Yokota T; Shishime E; Tsuda K; Mueller N
    J Acquir Immune Defic Syndr (1988); 1988; 1(4):340-5. PubMed ID: 3063808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of commercially available particle agglutination assay and enzyme-linked immunosorbent assay for screening of human T-cell leukemia virus type I antibodies in blood donors.
    Kobayashi S; Yoshida T; Hiroshige Y; Matsui T; Yamamoto N
    J Clin Microbiol; 1988 Feb; 26(2):308-12. PubMed ID: 2893807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the confirmatory test by western blotting assay (WB) for the detection of antibodies to adult T-cell leukemia virus type I. Analysis of the discrepancy between indirect immunofluorescence assay (IF), enzyme immunoassay (EIA) and gelatin particle agglutination assay (PA)].
    Nishimura Y; Yamaguchi K; Takatsuki K; Kiyokawa T; Imamura Y; Fujiwara H
    Rinsho Byori; 1989 Apr; 37(4):385-9. PubMed ID: 2664283
    [No Abstract]   [Full Text] [Related]  

  • 8. Performance certification of gelatin particle agglutination assay for anti-HTLV-1 antibody: inconclusive positive results.
    Maeda Y; Imai J; Kiyokawa H; Kanamura M; Hino S
    Jpn J Cancer Res; 1989 Oct; 80(10):915-9. PubMed ID: 2515175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of the confirmatory test of enzyme immunoassay and western blotting method in detection of anti-HTLV-1 in sera].
    Oita T; Fukuda K; Kasakura S
    Rinsho Byori; 1989 Jul; 37(7):774-8. PubMed ID: 2691735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of human T-cell lymphotropic virus type I among Dutch blood donors].
    Zaaijer HL; Dudok de Wit C; Cuypers HT; Winkel IN; Lelie PN
    Ned Tijdschr Geneeskd; 1993 Dec; 137(49):2541-3. PubMed ID: 8272141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
    Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
    Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-1 in Switzerland: low prevalence of specific antibodies in HIV risk groups, high prevalence of cross-reactive antibodies in normal blood donors.
    Schüpbach J; Baumgartner A; Tomasik Z
    Int J Cancer; 1988 Dec; 42(6):857-62. PubMed ID: 3192331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the human T-cell leukemia virus type I seropositivity of blood donors by the particle agglutination inhibition test.
    Kwon KW; Ikeda H; Yano M; Sekiguchi S
    Jpn J Cancer Res; 1989 Sep; 80(9):833-9. PubMed ID: 2513300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of immunoglobulin M and G Western blot and ELISA for screening antibodies to Treponema pallidum in blood donors.
    Wang LN; Li JM
    Sex Transm Dis; 2009 Jul; 36(7):413-6. PubMed ID: 19387420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of HTLV-I viral antibodies in donor blood samples].
    Iakovleva LS; Seniuta NB; Stepina VN; Gurtsevich VE; Buachidze LN
    Vopr Virusol; 1989; 34(2):174-6. PubMed ID: 2669334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of transmission of human T-lymphotropic virus type 1 (HTLV-1) through transfusion, by donor screening with antibody to the virus. One-year experience.
    Inaba S; Sato H; Okochi K; Fukada K; Takakura F; Tokunaga K; Kiyokawa H; Maeda Y
    Transfusion; 1989 Jan; 29(1):7-11. PubMed ID: 2643213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to human T-cell lymphotropic virus type I (HTLV-I) by particle agglutination (PA) test in Korean blood donors.
    Kim JM; Song YG; Oho YC; Park HC; Kwon KH; Kim E; Lee SH; Kim KH
    Yonsei Med J; 1999 Apr; 40(2):173-7. PubMed ID: 10333722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pretransfusion screening tests for HIV and HTLV-I in donated blood].
    Okubo S
    Rinsho Byori; 1989 Jul; 37(7):762-7. PubMed ID: 2607646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Search for antibodies against human T-cell lymphotropic virus type I (HTLV-I) in blood donors and risk groups].
    Silva Cabrera E; Pérez Guevara MT; Lubián Caballero AL; de la Fuente Arzola JL; Navea Leyva L; Cruz Sui O
    Rev Cubana Med Trop; 1997; 49(1):24-7. PubMed ID: 9685956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.